Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says

FOXNews.com

22 Jun 2020 0 shares 1 views

Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says

FOXNews.com

Published 22 Jun 2020

Remdesivir, which recently received emergency use approval to treat patients with COVID-19, will be tested in an inhaled version, biotech Gilead Sciences said on Monday.

Full Article

Related news coverage

Gilead Announces Clinical Trial For An Inhaled Version Of Remdesivir

Newsy 22 Jun 2020

Watch VideoGilead Sciences announced Monday it will start human clinical trials for an inhaled version of remdesivir as a potential..

NA Proactive news snapshot: Milestone Scientific, BetterLife Pharma, Revive Therapeutics, Matinas BioPharma, Biocept UPDATE …
Proactive Investors 30 Jun 2020
Coronavirus: China approves vaccine for military use, global deaths reach 500,000, US health secretary warns on infection surge...
Proactive Investors 29 Jun 2020
Tiziana Life Sciences "aggressively advancing" COVID-19 treatment and breakthrough delivery method
Proactive Investors 29 Jun 2020
MYOV To Report SPIRIT 1 Data, EVLO Joins COVID-19 Drug Race, NVTA Loosens Purse Strings
RTTNews 23 Jun 2020

More coverage

Gilead to Test a Version of Remdesivir That Can Be Inhaled

As scientists study the effectiveness of the drug against the coronavirus, others are exploring how to make the potential treatment..

NYTimes.com 22 Jun 2020

Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says

Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says

You might like

Related news coverage

Gilead Announces Clinical Trial For An Inhaled Version Of Remdesivir

Advertisement

More coverage

Gilead to Test a Version of Remdesivir That Can Be Inhaled